These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6846376)

  • 1. Relationship of lipid disorders to coronary heart disease.
    Glueck CJ
    Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European and American recommendations for coronary heart disease prevention.
    Wood D
    Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factor hyperlipidemia. Dealing with reality].
    Wolfram G
    MMW Munch Med Wochenschr; 1982 Feb; 124(5):91-2. PubMed ID: 6806637
    [No Abstract]   [Full Text] [Related]  

  • 13. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
    Dakovska L; Orbetzov M; Orbetzova V; Yarovska N
    Paroi Arterielle; 1981; 7(1):15-22. PubMed ID: 7339537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and lipoprotein tracking in 108 children over a four-year period.
    Laskarzewski P; Morrison JA; deGroot I; Kelly KA; Mellies MJ; Khoury P; Glueck CJ
    Pediatrics; 1979 Nov; 64(5):584-91. PubMed ID: 226923
    [No Abstract]   [Full Text] [Related]  

  • 20. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
    Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.